Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data
J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data
J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data
Submitted by
admin
on September 1, 2015 - 6:37pm
Source:
Fierce Pharma
News Tags:
JNJ
Bayer
Pfizer
Bristol-Myers Squibb
Eliquis
bloodthinners
Xarelto
Headline:
J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data
Do Not Allow Advertisers to Use My Personal information
